Skip to main content

Table 5 P values for each inflammatory parameter, pooled across all cognitive tests

From: Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy

C1-inh 0.22

C3bc 0.77

C4bc 0.79

Properdin 0.56

TCC 0.93

PPH0.29

ETP 0.19

Eotaxin0.52

FGF 0.17

G-CSF 0.47

GM-CSF 0.41

IFNÎł 0.19

MIP-1α 0.37

MIP-1ÎČ 0.01

IL-1ÎČ 0.18

IL-1RA 0.01

IL-2 0.04

IL-4 0.25

IL-5 0.11

IL-6 0.55

IL-7 0.69

IL-8 0.45

IL-9 0.05

IL-10 0.38

IL-12 0.01

IL-13 0.10

IL-15 0.56

IL-17 0.36

MCP-1 0.67

PAI 0.63

PDGF 0.44

RANTES 0.47

TNF-α 0.15

VEGF 0.40

IP-10 0.49

  1. C1-inh, C1-inhibitor; ETP, endogenous thrombin potential; FGF, fibroblast growth factor; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; IFNÎł, interferon-Îł; IL, interleukin; IL-1RA, interleukin-1 receptor antagonist; IL-1ÎČ, interleukin-1ÎČ, IP-10 (also known as C-X-C motif chemokine 10or CXCL10), interferon gamma-induced protein 10; MCP-1 (also known as CCL2), monocyte chemotactic protein-1; MIP-1α (also known as CCL3), macrophage inflammatory protein-1α; MIP-1ÎČ (also known as CCL4), macrophage inflammatory protein-1ÎČ; PAI, plasminogen activator inhibitor; PDGF, platelet-derived growth factor; PPH, plasmin peak height; RANTES (also known as CCL5), regulated on activation, normal T cell expressed and secreted; TCC, terminal complement complex; TNF-α, tumor necrosis factor-α; VEGF, vascular endothelial growth factor.